Browse by Condition in Dallas
And 62 more conditions with trials in Dallas
Recruiting Clinical Trials in Dallas
NCT05208762 · Phase 1 · Seagen, a wholly owned subsidiary of Pfizer
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
NCT05703971 · Phase 1/2 · Genprex, Inc.
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
NCT04682483 · Tufts Medical Center
Cardiogenic Shock Working Group Registry
NCT05892614 · Phase 2 · aTyr Pharma, Inc.
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
NCT07436728 · Phase 1/2 · Takeda
A Study of TAK-505 in Adults With Solid Tumors
NCT06038578 · Phase 2 · Toray Industries, Inc
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
NCT07419334 · Phase 3 · Alkeus Pharmaceuticals, Inc.
Study of ALK-001 on the Progression of Stargardt Disease
NCT07798648 · Phase 3 · BioNTech SE
A Study of COVID-19 Vaccine(s) in Children and Adults
NCT04422912 · Phase 1/2 · Cabaletta Bio
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
NCT05365581 · Phase 1 · Astellas Pharma Global Development, Inc.
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
NCT05691465 · Phase 2 · National Cancer Institute (NCI)
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
NCT06265103 · Epilepsy Foundation of America
Epilepsy Learning Healthcare System (ELHS)
Top Study Sponsors in Dallas
| Sponsor | Recruiting studies |
|---|---|
| University of Texas Southwestern Medical Center | 146 |
| Baylor Research Institute | 18 |
| Methodist Health System | 17 |
| VA Office of Research and Development | 10 |
| The University of Texas at Dallas | 8 |
| Eli Lilly and Company | 6 |
| M.D. Anderson Cancer Center | 6 |
| Novartis Pharmaceuticals | 5 |
Trials in Dallas by Phase
| Phase | Studies |
|---|---|
| Early Phase 1 | 7 |
| Phase 1 | 81 |
| Phase 1/2 | 68 |
| Phase 2 | 83 |
| Phase 2/3 | 6 |
| Phase 3 | 41 |
| Phase 4 | 20 |
| Not phased | 301 |
94 of these studies accept healthy volunteers.
Clinical Trials in Dallas: Common Questions
How many clinical trials are recruiting in Dallas, TX?
607 clinical trials list a recruiting site in Dallas, TX, across 92 conditions on HelloStudys. Counts update daily from ClinicalTrials.gov.
What conditions are being studied in Dallas?
The most active research areas in Dallas right now are ankylosing spondylitis, rheumatoid arthritis, advanced solid tumors. Browse by condition above to see each study.
Who sponsors clinical trials in Dallas?
The sponsors with the most recruiting studies in Dallas include University of Texas Southwestern Medical Center, Baylor Research Institute, Methodist Health System.
Are there clinical trials for healthy volunteers in Dallas?
Yes. 94 of the recruiting studies in Dallas accept healthy volunteers.
Does it cost anything to join a clinical trial?
Study-related visits, tests and treatment are typically provided at no cost to participants, and some studies reimburse travel or time. Each study sets its own terms, so confirm with the study team before enrolling.
About Clinical Trials in Dallas, TX
Dallas, TX is home to 607 actively recruiting clinical trials across 92 medical conditions as of 2026. The most active research areas include ankylosing spondylitis, rheumatoid arthritis, advanced solid tumors. Clinical trials offer free access to new treatments and expert medical care. Participation is always voluntary, and you can withdraw at any time.